Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 4Condylomata Acuminata 4Anus Neoplasms 4Vulvar Neoplasms 3Papillomavirus Infections 3Vaginal Neoplasms 2Colonic Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Lung Neoplasms 1Diabetes Mellitus, Insulin-Dependent, 12 1Colorectal Neoplasms 1Breast Neoplasms 1Anal Canal Carcinoma 1Adenoviridae Infections 1

Interventions

Fluorouracil 9Radiotherapy 7Cisplatin 7Radiotherapy, Intensity-Modulated 4Mitomycin 4Magnetic Resonance Spectroscopy 4Specimen Handling 3Radiation 3Nivolumab 3Capecitabine 3dehydroftorafur 2Taxes 2Paclitaxel 2Cetuximab 2Carboplatin 2Biopsy 2toripalimab 1rocakinogene sifuplasmid 1pembrolizumab 1durvalumab 1atezolizumab 1X-Rays 1Watchful Waiting 1Vaccines 1VGX-3100 1Sigmoidoscopy 1Radiosurgery 1Proctoscopy 1Platinum 1Phantoms, Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anal Canal Carcinoma × Vaccines × Gastrointestinal × Clear all
NCT03946358 2024-12-20

VolATIL

Centre Hospitalier Universitaire de Besancon

Phase 2 Completed
47 enrolled
GastrointestinalGynecologicHead & Neck

Anal Canal Carcinoma, Squamous Cell Carcinoma of Head and Neck, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡